LGALS8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.633750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.810180E-01
Normal-vs-Stage2
2.086600E-01
Normal-vs-Stage3
1.238240E-02
Normal-vs-Stage4
3.918000E-01
Stage1-vs-Stage2
8.826600E-01
Stage1-vs-Stage3
1.742410E-01
Stage1-vs-Stage4
8.053800E-01
Stage2-vs-Stage3
1.381810E-01
Stage2-vs-Stage4
8.585400E-01
Stage3-vs-Stage4
2.014400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.424040E-01
Normal-vs-AfricanAmerican
3.134000E-01
Normal-vs-Asian
4.721000E-01
Caucasian-vs-AfricanAmerican
4.981800E-01
Caucasian-vs-Asian
3.873000E-01
AfricanAmerican-vs-Asian
9.931000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.156600E-01
Normal-vs-Female
1.183020E-01
Male-vs-Female
5.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.414200E-01
Normal-vs-Age(41-60Yrs)
4.324200E-01
Normal-vs-Age(61-80Yrs)
1.029800E-01
Normal-vs-Age(81-100Yrs)
3.814300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.104800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.012600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.954200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.201400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.129900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.801800E-02
Normal-vs-Daily Drinker
4.976000E-02
Normal-vs-Weekly Drinker
2.673600E-01
Normal-vs-Occasional Drinker
6.670600E-01
Normal-vs-Social Drinker
2.323800E-01
Non Drinker-vs-Daily Drinker
2.862400E-01
Non Drinker-vs-Weekly Drinker
6.768400E-01
Non Drinker-vs-Occasional Drinker
9.360400E-03
Non Drinker-vs-Social Drinker
1.406610E-01
Daily Drinker-vs-Weekly Drinker
2.801400E-01
Daily Drinker-vs-Occasional Drinker
3.044300E-03
Daily Drinker-vs-Social Drinker
3.848200E-02
Weekly Drinker-vs-Occasional Drinker
1.373050E-01
Weekly Drinker-vs-Social Drinker
5.022200E-01
Occasional Drinker-vs-Social Drinker
2.894600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.384200E-02
Normal-vs-Grade 2
3.441400E-03
Normal-vs-Grade 3
1.081230E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.941700E-02
Grade 1-vs-Grade 3
7.017600E-03
Grade 1-vs-Grade 4
4.384200E-02
Grade 2-vs-Grade 3
3.335200E-01
Grade 2-vs-Grade 4
3.441400E-03
Grade 3-vs-Grade 4
1.081230E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.505770E-01
Normal-vs-NonDiabetic
1.390960E-01
Diabetic-vs-NonDiabetic
8.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.145800E-01
Normal-vs-NoPancreatitis
1.403550E-01
Pancreatitis-vs-NoPancreatitis
7.474600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.586780E-01
Normal-vs-N1
1.678200E-01
N0-vs-N1
8.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.542200E-01
Normal-vs-TP53-NonMutant
2.173200E-01
TP53-Mutant-vs-TP53-NonMutant
6.466200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
